Global Cell Cryopreserving Agent Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Cell Cryopreserving Agent Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Cell culture are prone to genetic drift, which are susceptible to microbial contamination. The microbial contamination can lead to experiment failure in laboratories. Beside the cell line are very valuable resource and replacing the cell line will be too costly and time consuming during the experimentation. The best method to store cell line with minimum cost is freezing. The freezing method will enable the long term storage of cell which can be utilized when required in the laboratories. When the small surplus are available for sub culturing, it should be frozen as seed stock therefore duplicates can be obtain when require during experimentation. Cryopreserving is the most widely used method for the preservation of cell culture. In cryopreserving method the cell lines are stored in liquid nitrogen to avoid the microbial contamination. The presence of cryopreserving agents such as dimethylsulfoxide (DMSO) allows slower cooler rate and reduce the rate of ice crystal formation.
Cell Cryopreserving Agent report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cell Cryopreserving Agent market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Research Institutes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cell Cryopreserving Agent industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Cell Cryopreserving Agent key manufacturers include Merck, Thermo Fisher Scientific, Nippon Genetics, Miltenyi Biotec, BioLifeSolutions, PromoCell, KOHJIN Life Sciences Co.,Ltd, Abcam and ROKEPIE®BV, etc. Merck, Thermo Fisher Scientific, Nippon Genetics are top 3 players and held % sales share in total in 2022.
Cell Cryopreserving Agent can be divided into DMSO (10%), 10% Glycerol, Without DMSO and Others, etc. DMSO (10%) is the mainstream product in the market, accounting for % sales share globally in 2022.
Cell Cryopreserving Agent is widely used in various fields, such as Hospitals, Research Institutes, Laboratories and Pharmaceuticals, etc. Hospitals provides greatest supports to the Cell Cryopreserving Agent industry development. In 2022, global % sales of Cell Cryopreserving Agent went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cell Cryopreserving Agent market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck
Thermo Fisher Scientific
Nippon Genetics
Miltenyi Biotec
BioLifeSolutions
PromoCell
KOHJIN Life Sciences Co.,Ltd
Abcam
ROKEPIE®BV
Biological Industries
Nacalai Tesque Inc.
Segment by Type
DMSO (10%)
10% Glycerol
Without DMSO
Others
Hospitals
Research Institutes
Laboratories
Pharmaceuticals
Biotechnology Companies
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Cell Cryopreserving Agent market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cell Cryopreserving Agent, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cell Cryopreserving Agent industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Cell Cryopreserving Agent in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cell Cryopreserving Agent introduction, etc. Cell Cryopreserving Agent Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Cell Cryopreserving Agent market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Cell Cryopreserving Agent report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Cell Cryopreserving Agent market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Research Institutes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Cell Cryopreserving Agent industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Cell Cryopreserving Agent key manufacturers include Merck, Thermo Fisher Scientific, Nippon Genetics, Miltenyi Biotec, BioLifeSolutions, PromoCell, KOHJIN Life Sciences Co.,Ltd, Abcam and ROKEPIE®BV, etc. Merck, Thermo Fisher Scientific, Nippon Genetics are top 3 players and held % sales share in total in 2022.
Cell Cryopreserving Agent can be divided into DMSO (10%), 10% Glycerol, Without DMSO and Others, etc. DMSO (10%) is the mainstream product in the market, accounting for % sales share globally in 2022.
Cell Cryopreserving Agent is widely used in various fields, such as Hospitals, Research Institutes, Laboratories and Pharmaceuticals, etc. Hospitals provides greatest supports to the Cell Cryopreserving Agent industry development. In 2022, global % sales of Cell Cryopreserving Agent went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cell Cryopreserving Agent market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck
Thermo Fisher Scientific
Nippon Genetics
Miltenyi Biotec
BioLifeSolutions
PromoCell
KOHJIN Life Sciences Co.,Ltd
Abcam
ROKEPIE®BV
Biological Industries
Nacalai Tesque Inc.
Segment by Type
DMSO (10%)
10% Glycerol
Without DMSO
Others
Segment by Application
Hospitals
Research Institutes
Laboratories
Pharmaceuticals
Biotechnology Companies
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Cell Cryopreserving Agent market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Cell Cryopreserving Agent, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Cell Cryopreserving Agent industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Cell Cryopreserving Agent in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Cell Cryopreserving Agent introduction, etc. Cell Cryopreserving Agent Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Cell Cryopreserving Agent market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.